2 results
Approved WMOCompleted
To evaluate the safety and clinical performance of the LCP system in patients who are indicated for VVI(R) pacemaker.
Approved WMOCompleted
The study will look at patients with relapsed (returned after prior treatment) and refractory (not responsive to prior treatment) multiple myeloma. The research aims to compare a new drug called elotuzamab combined with standard of care (…